AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25632576 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal-cake-separated moxibustion combined with acupuncture
Number of subjects: 114
Study 25632576 — intervention group
Group type: COMPARATOR
Intervention: Manual acupuncture stimulation combined with wheat-flour-cake separated moxibustion
Number of subjects: 114
Study 22818965 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 102
Study 22818965 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Hill repair (LHR)
Number of subjects: 102
Study 22818965 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 102
Study 20460061 — intervention group
Group type: EXPERIMENTAL
Intervention: Weightbearing multiplanar imaging in patients with lateral hindfoot pain
Number of subjects: 20
Study 20460061 — intervention group
Group type: COMPARATOR
Intervention: Weightbearing multiplanar imaging in patients without lateral hindfoot pain
Number of subjects: 20
Study 17582403 — intervention group
Group type: EXPERIMENTAL
Intervention: Headfirst sperm injection
Number of subjects: 25
Study 17582403 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailfirst sperm injection
Number of subjects: 25
Study 17582403 — intervention group
Group type: COMPARATOR
Intervention: Transfer of embryos (either headfirst or tailfirst)
Number of subjects: 25
Study 15632836 — intervention group
Group type: EXPERIMENTAL
Intervention: St Jude Medical ATG coronary connector system (n = 30)
Number of subjects: 60
Study 15632836 — intervention group
Group type: COMPARATOR
Intervention: Hand sewn anastomoses (n = 30)
Number of subjects: 60
Study 11874944 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg once daily
Number of subjects: 22
Study 11874944 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 200 mg once daily
Number of subjects: 22
Study 10197663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine infusion (0.7 to 1.4 microg x kg(‐1) x min(‐1))
Number of subjects: 77
Study 10197663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (0.5 to 1 microg x kg(‐1) x min(‐1))
Number of subjects: 77
Study 10197663 — intervention group
Group type: COMPARATOR
Intervention: Control group (neither medication)
Number of subjects: 77
Study 8536298 — intervention group
Group type: EXPERIMENTAL
Intervention: Instantaneous axis of rotation (IAR) of the C2-3 segment
Number of subjects: 0
Study 8536298 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic blocks of the C2-3 zygapophysial joint
Number of subjects: 0
Study 2181103 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 31
Study 2181103 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram
Number of subjects: 31
Study 2181103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 2181103 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of theophylline and doxapram
Number of subjects: 31
Study 7000030 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 40
Study 7000030 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine hydrochloride
Number of subjects: 40
Study 7000030 — intervention group
Group type: COMPARATOR
Intervention: Methscopolamine bromide
Number of subjects: 40
Study 7000030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30649523 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-focused MNCH package
Number of subjects: 0
Study 30649523 — intervention group
Group type: COMPARATOR
Intervention: Standard MNCH package
Number of subjects: 0
Study 29174079 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant administered through a laryngeal mask airway (LMA)
Number of subjects: 103
Study 29174079 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surfactant administered, maintained on CPAP)
Number of subjects: 103
Study 27015158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (communication of the result and offer of psychiatric evaluation and treatment free of charge; N=56)
Number of subjects: 115
Study 27015158 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback on test result for 3 months; N=59)
Number of subjects: 115
Study 25310220 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg press strength training
Number of subjects: 23
Study 25310220 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 23
Study 22659190 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD) 30 mg/m² and carboplatin AUC 5 plus bevacizumab 10 mg/kg
Number of subjects: 54
Study 22659190 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD) and carboplatin plus bevacizumab
Number of subjects: 54
Study 20424191 — intervention group
Group type: EXPERIMENTAL
Intervention: mCIMT-BiT (6 weeks of modified constraint-induced movement therapy followed by 2 weeks of bimanual task-specific training)
Number of subjects: 52
Study 20424191 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (1.5 hours of general physical or occupational therapy weekly plus encouragement to use the affected hand)
Number of subjects: 52
Study 17700049 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone plus clinical management
Number of subjects: 193
Study 17700049 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 193
Study 17700049 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and IPT
Number of subjects: 193
Study 17700049 — intervention group
Group type: COMPARATOR
Intervention: Combination of IPT and pill-placebo
Number of subjects: 193
Study 16267611 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen for 1 year
Number of subjects: 265
Study 16267611 — intervention group
Group type: COMPARATOR
Intervention: Observation for 1 year
Number of subjects: 265
Study 12383805 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty (ALT)
Number of subjects: 591
Study 12383805 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 591
Study 10355150 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast with 400 microgram of BDP
Number of subjects: 41
Study 10355150 — intervention group
Group type: COMPARATOR
Intervention: Control group (400 microgram BDP alone)
Number of subjects: 41
Study 11921899 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 0
Study 11921899 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrocentesis
Number of subjects: 0
Study 1935543 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern electroretinograms with 12' and 30' checkerboard stimuli and 1 c/deg and 2.5 c/deg vertical gratings
Number of subjects: 12
Study 1935543 — intervention group
Group type: COMPARATOR
Intervention: Cone electroretinograms elicited by ganzfeld stimulation
Number of subjects: 12
Study 1935543 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital filtering using a bandpass of 1-40 Hz
Number of subjects: 12
Study 1935543 — intervention group
Group type: COMPARATOR
Intervention: Broadband analogue-filtered pattern electroretinograms
Number of subjects: 12
Study 6139100 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 0
Study 6139100 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 0
Study 31171436 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 91
Study 31171436 — intervention group
Group type: COMPARATOR
Intervention: No β-blockers
Number of subjects: 91
Study 29095992 — intervention group
Group type: EXPERIMENTAL
Intervention: tocilizumab plus MTX
Number of subjects: 317
Study 29095992 — intervention group
Group type: EXPERIMENTAL
Intervention: tocilizumab
Number of subjects: 317
Study 29095992 — intervention group
Group type: COMPARATOR
Intervention: MTX
Number of subjects: 317
Study 29095992 — intervention group
Group type: EXPERIMENTAL
Intervention: tocilizumab arms
Number of subjects: 317
Study 26936901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy Outreach Worker (POW) service
Number of subjects: 1324
Study 26936901 — intervention group
Group type: COMPARATOR
Intervention: Standard maternity care (control)
Number of subjects: 1324
Study 24721447 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbicide gel use
Number of subjects: 150
Study 24721447 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 150
Study 22179440 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscope-assisted surgery
Number of subjects: 25
Study 22179440 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 25
Study 20604701 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended VBRT (36-week)
Number of subjects: 130
Study 20604701 — intervention group
Group type: COMPARATOR
Intervention: Standard VBRT (12-week)
Number of subjects: 130
Study 20604701 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Extended and Standard VBRT
Number of subjects: 130
Study 19232163 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Based Learning (PBL)
Number of subjects: 40
Study 19232163 — intervention group
Group type: COMPARATOR
Intervention: Traditional Lecture
Number of subjects: 40
Study 15955950 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TENS)
Number of subjects: 10
Study 15955950 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10
Study 11805771 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic envelope flap
Number of subjects: 60
Study 11805771 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified triangular flap
Number of subjects: 60
Study 11805771 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall result
Number of subjects: 60
Study 10609207 — intervention group
Group type: EXPERIMENTAL
Intervention: dorzolamide 2%
Number of subjects: 102
Study 10609207 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost 0.005%
Number of subjects: 102
Study 10609207 — intervention group
Group type: COMPARATOR
Intervention: control (no treatment)
Number of subjects: 102
Study 7728364 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of major depression before admission
Number of subjects: 82
Study 7728364 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of major depression after detoxification
Number of subjects: 82
Study 2058054 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Rolling Rod
Number of subjects: 0
Study 2058054 — intervention group
Group type: COMPARATOR
Intervention: Control group (halved frame fitting)
Number of subjects: 0
Study 7051564 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin, 75 mg daily for 8.5 months (6-13 months)
Number of subjects: 38
Study 7051564 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole, 150 mg daily for 3 days, two times a month for 14 months (6.5-30 months)
Number of subjects: 38
Study 7051564 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined immuno-suppressive and anticoagulant treatment (azathioprin, heparin, acenocoumarol) for 15 months (6-35 months)
Number of subjects: 38
Study 7051564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 38
Study 30778687 — intervention group
Group type: COMPARATOR
Intervention: Visual inspection alone
Number of subjects: 126
Study 30778687 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic examination
Number of subjects: 126
Study 29121988 — intervention group
Group type: EXPERIMENTAL
Intervention: Banha-sasim-tang (BST)
Number of subjects: 0
Study 29121988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25614531 — intervention group
Group type: EXPERIMENTAL
Intervention: Package of measures including regular postcards and problem-solving therapy
Number of subjects: 0
Study 25614531 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 24361109 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 110
Study 24361109 — intervention group
Group type: COMPARATOR
Intervention: Placebo SMT
Number of subjects: 110
Study 24361109 — intervention group
Group type: COMPARATOR
Intervention: Placebo SMT with instructional set
Number of subjects: 110
Study 24361109 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 110
Study 22381065 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help manual in addition to standard care and treatment
Number of subjects: 54
Study 22381065 — intervention group
Group type: COMPARATOR
Intervention: Standard care and treatment
Number of subjects: 54
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers at both admission and discharge
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers at admission only
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers at discharge only
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: No beta blockers at either point
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers prescribed at discharge
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent beta blockers at randomization and discharge
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers in patients with impaired and preserved systolic left ventricular function
Number of subjects: 14703
Study 19576338 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of valsartan, captopril, and beta blockers
Number of subjects: 14703
Study 17284733 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA diet (6.5% of energy)
Number of subjects: 23
Study 17284733 — intervention group
Group type: COMPARATOR
Intervention: LA diet (12.6% of energy)
Number of subjects: 23
Study 17284733 — intervention group
Group type: COMPARATOR
Intervention: Average American diet (AAD)
Number of subjects: 23
Study 17979578 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at doses of 1.25, 2.5, 5, and 7.5 mg administered three times per day (t.i.d.)
Number of subjects: 165
Study 17979578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 15235821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cremophor EL (CrEL) 20 ml/m2 (equivalent to 175 mg/m2 paclitaxel)
Number of subjects: 16
Study 15235821 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study 10841226 — intervention group
Group type: EXPERIMENTAL
Intervention: Early symptom‐limited exercise test (ET)
Number of subjects: 1173
Study 10841226 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T (TnT) levels
Number of subjects: 1173
Study 10841226 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ET results and TnT levels
Number of subjects: 1173
Study 9398965 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg‐kg‐1 lidocaine
Number of subjects: 100
Study 9398965 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 microgram‐1.kg‐1.min‐1 PGE1
Number of subjects: 100
Study 9398965 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 microgram‐1.kg‐1.min‐1 PGE1 plus injection of 1 mg‐1.kg‐1 lidocaine
Number of subjects: 100
Study 9398965 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 10149693 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric bag-mask (PBM)
Number of subjects: 50
Study 10149693 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult bag-mask (ABM)
Number of subjects: 50
Study 10149693 — intervention group
Group type: COMPARATOR
Intervention: Mouth-to-mask (M-Ma)
Number of subjects: 50
Study 10149693 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway patency group (n=36)
Number of subjects: 50
Study 3895752 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrol
Number of subjects: 0
Study 3895752 — intervention group
Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 0
Study 3895752 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 0
Study 31307899 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait Exercise Assist Robot (GEAR)
Number of subjects: 26
Study 31307899 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 27632676 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation readiness test
Number of subjects: 1042
Study 26365452 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐min soft music intervention for 3 days
Number of subjects: 112
Study 26365452 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 112
Study 23206319 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD6765 (150 mg)
Number of subjects: 22
Study 23206319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 21481253 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVE! treatment plus PDA (PDA+)
Number of subjects: 0
Study 21481253 — intervention group
Group type: COMPARATOR
Intervention: MOVE! treatment alone (Standard Care)
Number of subjects: 0
Study 19835582 — intervention group
Group type: COMPARATOR
Intervention: 0 g of GILP
Number of subjects: 10
Study 19835582 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of GILP
Number of subjects: 10
Study 19835582 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of GILP
Number of subjects: 10
Study 19835582 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of GILP
Number of subjects: 10
Study 16462287 — intervention group
Group type: EXPERIMENTAL
Intervention: RRV‐TV vaccine during the neonatal period
Number of subjects: 90
Study 16462287 — intervention group
Group type: COMPARATOR
Intervention: RRV‐TV vaccine at 2 months of age
Number of subjects: 90
Study 16462287 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dose schedule initiated in the neonatal period
Number of subjects: 90
Study 16462287 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-2-4 month schedule
Number of subjects: 90
Study 15313740 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-knee compression elastic stockings (30 to 40 mm Hg at the ankle) for 2 years
Number of subjects: 180
Study 15313740 — intervention group
Group type: COMPARATOR
Intervention: Control group (no elastic stockings)
Number of subjects: 180
Study 11133631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 60
Study 11133631 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.15%
Number of subjects: 60
Study 9570600 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg epidural bupivacaine diluted in 4 mL (0.5%)
Number of subjects: 58
Study 9570600 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg epidural bupivacaine diluted in 10 mL (0.2%)
Number of subjects: 58
Study 9570600 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg epidural bupivacaine diluted in 20 mL (0.1%)
Number of subjects: 58
Study 7831456 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 41
Study 7831456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 3279410 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 10
Study 3279410 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10
Study 3279410 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 10
Study 29052964 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychoeducation for caregivers conducted in 4 interactive sessions, once per week.
Number of subjects: 0
Study 29052964 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 0
Study 28693454 — intervention group
Group type: EXPERIMENTAL
Intervention: JolinchenKids - Fit and Healthy in Daycare program
Number of subjects: 1360
Study 28693454 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention control group
Number of subjects: 1360
Study 25479050 — intervention group
Group type: EXPERIMENTAL
Intervention: mobile device delivered interactive intervention
Number of subjects: 82
Study 25479050 — intervention group
Group type: COMPARATOR
Intervention: paper-and-pencil mood monitoring
Number of subjects: 82
Study 23480308 — intervention group
Group type: EXPERIMENTAL
Intervention: High-priced cosmeceuticals
Number of subjects: 44
Study 23480308 — intervention group
Group type: COMPARATOR
Intervention: More affordable cosmeceuticals
Number of subjects: 44
Study 21496343 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of three targeted pictorial messages regarding vaccines; administered by trained community health workers.
Number of subjects: 366
Study 21496343 — intervention group
Group type: COMPARATOR
Intervention: General health promotion messages based on Pakistan's Lady Health Worker program curriculum; control group.
Number of subjects: 366
Study 18166837 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video (18-minute video about clinical trials)
Number of subjects: 126
Study 18166837 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 126
Study 16615955 — intervention group
Group type: EXPERIMENTAL
Intervention: Early provision of parenteral amino acids (AA) > or =3 g/kg per day at < or =5 days of life (n = 182)
Number of subjects: 1018
Study 16615955 — intervention group
Group type: COMPARATOR
Intervention: Late provision of parenteral amino acids (AA) (n = 836)
Number of subjects: 1018
Study 16615955 — intervention group
Group type: EXPERIMENTAL
Intervention: Early provision of parenteral amino acids (AA) (n = 182)
Number of subjects: 1018
Study 14704633 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine 3i2 g/day (group A)
Number of subjects: 32
Study 14704633 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine 3i4 g/day (group B)
Number of subjects: 32
Study 11093966 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg daily for 12 weeks
Number of subjects: 175
Study 11093966 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 175
Study 9088819 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 4 micrograms kg‐1
Number of subjects: 45
Study 9088819 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 70 micrograms kg‐1
Number of subjects: 45